Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Change in Account Payables (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Change in Account Payables for 2 consecutive years, with $524000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Change in Account Payables rose 120.08% to $524000.0 in Q4 2025 year-over-year; TTM through Oct 2025 was $815000.0, a N/A change, with the full-year FY2025 number at $2.8 million, down 61.28% from a year prior.
  • Change in Account Payables was $524000.0 for Q4 2025 at Kestra Medical Technologies, up from -$2.9 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $3.4 million in Q1 2025 to a low of -$2.9 million in Q3 2025.